Myomectomy vs Hysterectomy for Fibroids: How to Choose
Reading time: about 7 minutes. This article is educational and does not replace an individual consultation.
If you have fibroids and surgery is being discussed, you will likely hear two very different operations mentioned: myomectomy and hysterectomy. Both can relieve heavy bleeding, pain and pressure — but they are not interchangeable, and choosing between them is rarely about which operation is “better” in the abstract. It is about which operation is right for your fibroids, your fertility plans, and your priorities.
In short: myomectomy removes the fibroids and keeps the uterus — preferred when future pregnancy matters or a woman simply wishes to keep her uterus. Hysterectomy removes the uterus itself and is the only treatment that ensures fibroids cannot recur, because no uterus remains for new fibroids to grow in — appropriate when childbearing is complete, symptoms are severe, or fibroids keep recurring despite conservative treatment. Neither is automatically the “bigger” or “better” operation; the right choice depends on your individual situation.
Two goals, one set of fibroids
Fibroids (leiomyomas) are benign uterine muscle growths, common by the later reproductive years, though only some need treatment. When medical options — a hormonal intrauterine device, tranexamic acid, or a short, monitored course of ulipristal acetate — have not controlled bleeding, pain or pressure, surgery becomes reasonable. The conversation should then genuinely be a choice between two goals: treating the fibroids while preserving the uterus (myomectomy), or removing the uterus altogether as a definitive solution (hysterectomy). ACOG guidance is explicit that many women benefit from, and actively seek, options other than hysterectomy, and that treatment goals should be defined individually, not assumed.
What each operation involves
A myomectomy removes the individual fibroids and repairs the uterine muscle, leaving the uterus in place and able, in principle, to carry a future pregnancy. It can be done hysteroscopically (through the cervix, no incision, for fibroids bulging into the cavity), laparoscopically or robotically, or through an open incision for especially large or numerous fibroids. A hysterectomy removes the uterus itself — and with it, the fibroids, permanently — vaginally, laparoscopically, robotically or through an open incision, with or without the cervix or ovaries depending on the case. Our fibroid surgery (myomectomy) and laparoscopic hysterectomy pages describe each in more detail.
Why fibroid type and location matter
Gynaecologists classify fibroids by where they sit in the uterine wall, using the FIGO system: submucosal fibroids bulge into the cavity, intramural fibroids sit within the muscle wall, and subserosal fibroids project from the outer surface. A small submucosal fibroid may be removed hysteroscopically as a day case; multiple large intramural fibroids may need a more extensive laparoscopic or open myomectomy; and a uterus so replaced by fibroid tissue that little healthy muscle remains for a durable repair may not be a good candidate for myomectomy at all. Accurate mapping — a good pelvic ultrasound, with MRI when the picture is complex — genuinely shapes which operation is realistic.
The case for myomectomy — when keeping the uterus is the priority
Myomectomy is recommended when a woman wants to preserve fertility, or simply wishes to keep her uterus. It is the appropriate operation for most women with symptomatic submucosal or cavity-distorting fibroids who genuinely desire a future pregnancy — a position reflected consistently in current guidance. What it does not offer is protection against future fibroids: the underlying tendency to form them remains, so new ones can develop, occasionally needing further treatment — a trade-off usually well worth it, but one to discuss honestly before surgery, not after.
The case for hysterectomy — when it is the right choice
Hysterectomy remains the leading indication for the operation worldwide: it is the one treatment that definitively and permanently resolves fibroid symptoms, because no uterus remains for new fibroids to grow in. It is generally more appropriate when childbearing is complete and symptoms significantly affect quality of life, when fibroids have recurred after a previous myomectomy, when the uterus is too extensively replaced by fibroid tissue for a durable repair, when abnormal bleeding needs the uterus itself examined, or when a fully informed woman simply prefers a definitive answer. Choosing hysterectomy is not a “bigger” or more aggressive decision than myomectomy — it is the right decision for a different set of priorities, and should never be the automatic option when fertility or uterine preservation matters to the patient.
Why the surgical route matters as much as the operation
How an operation is performed matters almost as much as which one is chosen. ACOG guidance on choosing the route of hysterectomy recommends a minimally invasive approach — vaginal or laparoscopic — whenever feasible, since it means less blood loss, less pain, a shorter stay and a faster return to normal activity than an open incision. The same principle applies to myomectomy: laparoscopic, robotic or hysteroscopic myomectomy generally offer a gentler recovery than an open approach when fibroid number, size and position allow it. This is a separate, equally important conversation from which operation to have, and should be guided by an experienced laparoscopic surgical team assessing your specific anatomy.
A safety point worth knowing: morcellation
During some laparoscopic myomectomies and hysterectomies, fibroid tissue is cut into smaller pieces (morcellated) to be removed through small incisions. Since 2014, the FDA, ACOG, AAGL and ESGE have advised that patients be counselled about a small but real risk: occasionally, what looks like an ordinary fibroid on imaging is found, after surgery, to be an unsuspected uterine sarcoma — a rare cancer that morcellation could inadvertently spread if not anticipated. Good practice is to discuss this risk with every patient beforehand, review imaging and risk factors such as age and rapid fibroid growth carefully, and use a specimen containment bag whenever morcellation is performed. This is genuinely rare and should not by itself discourage minimally invasive surgery — but it belongs in your consent conversation.
Comparing the honest risks and recovery
Both operations carry the general risks of pelvic surgery — bleeding, infection, injury to nearby organs, and small anaesthetic risks — which minimally invasive routes reduce but do not eliminate. Myomectomy carries one specific consideration: because the uterine muscle is cut and repaired, there is a small risk of bleeding needing transfusion, and the repair needs to heal before a future pregnancy is attempted. Hysterectomy avoids that consideration entirely but is, by definition, the larger and irreversible operation, and ends any possibility of future pregnancy. Recovery is shaped far more by surgical route (keyhole versus open) than by which operation was performed; our week-by-week recovery guide covers both in detail.
Myomectomy, fertility, and the recurrence question
For women who want to conceive, myomectomy for fibroid-related infertility measurably improves the chance of pregnancy compared with leaving cavity-distorting fibroids untreated, and most cohorts report favourable pregnancy rates when no other fertility factor is present. The honest counterpoint is recurrence: one long-term follow-up study of over 200 women found a cumulative recurrence rate of about 5% at two years, rising to roughly 21% at five years, with an age of 30–40 at surgery and more than one fibroid removed both associated with a significantly higher chance of recurrence. These figures come from one cohort and vary between studies — general evidence, not a personal prediction — but the practical message holds: if fertility is the goal, it is usually sensible not to delay conception unnecessarily once healed, and to discuss your own age, fibroid number and ovarian reserve frankly, an assessment we coordinate with our fertility and IVF programme when needed.
Alternatives worth knowing about before deciding
Surgery is not the only option. For fibroids under about 3 cm without cavity distortion, a hormonal intrauterine system is recommended first-line. For larger fibroids, ulipristal acetate — used intermittently with monitored liver function since its licence was restricted after rare serious liver injury — may help when surgery or embolisation is unsuitable or has failed. Uterine artery embolisation (UAE) suits women who are not good surgical candidates or prefer to avoid surgery; trial evidence shows comparable medium-term symptom relief to myomectomy, though with a higher chance of needing a further procedure later. Myomectomy is generally associated with better pregnancy and live-birth outcomes than UAE, which can also affect ovarian reserve — so UAE is usually reserved for women who have completed, or do not want, childbearing. Endometrial ablation suits some women who have completed their family, but is not compatible with a future pregnancy.
How we help you reach the right decision
No single algorithm fits every woman with fibroids. In practice the decision weighs several honest inputs: your age and how strongly you want to preserve fertility; the number, size and location of your fibroids on imaging; how severely symptoms affect your daily life; whether you have already tried medical treatment or a previous myomectomy; and your own preference once you understand the real trade-offs. Our approach follows the same principle we apply to all benign uterine conditions: preserve the uterus and fertility wherever reasonable, and reserve hysterectomy for when it is genuinely the better choice for that woman — never as a default.
Questions worth asking at your consultation
- Based on my fibroids’ size, number and location, is myomectomy technically realistic for me?
- What surgical route would you use, and why — keyhole, robotic, or open?
- If I choose myomectomy, what is my realistic chance of needing further treatment later?
- How would this affect a future pregnancy, and when would it be safe to try?
- If morcellation might be used, how would we assess and reduce the associated risks beforehand?
- What would change your recommendation from myomectomy to hysterectomy, or vice versa?
Care in Ahmedabad, and when to seek advice
At Balaji Horizon Women’s Hospital on Science City Road, Ahmedabad, fibroid surgery is planned around the individual woman: careful imaging to map your fibroids, an honest discussion of both options where both genuinely apply, and a minimally invasive approach wherever your anatomy allows it. If you have heavy periods, pelvic pressure or pain, or fibroids found on a scan, an individual assessment is the right next step — earlier discussion leaves more options open, especially if fertility is part of your plan. Reach our team through the contact page, or start with our fibroids overview; if your bleeding pattern is unclear, our adenomyosis vs fibroids comparison may help.
References
- American College of Obstetricians and Gynecologists. Management of Symptomatic Uterine Leiomyomas. ACOG Practice Bulletin No. 228. Obstetrics & Gynecology. 2021.
- American College of Obstetricians and Gynecologists. Choosing the Route of Hysterectomy for Benign Disease. ACOG Committee Opinion No. 701. Obstetrics & Gynecology. 2017.
- Munro MG, Critchley HOD, Fraser IS, for the FIGO Working Group on Menstrual Disorders. The FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3–13.
- Radosa MP, Owsianowski Z, Mothes A, et al. Long-term risk of fibroid recurrence after laparoscopic myomectomy. Eur J Obstet Gynecol Reprod Biol. 2014;180:35–39. doi:10.1016/j.ejogrb.2014.05.029
- de Bruijn AM, Ankum WM, Reekers JA, et al. Uterine artery embolisation or myomectomy for women with uterine fibroids: four-year follow-up results of a randomised controlled trial. Am J Obstet Gynecol. 2016 (long-term follow-up subsequently reported to 2021).
- National Institute for Health and Care Excellence. Heavy menstrual bleeding: assessment and management. NICE guideline NG88; 2021 (exceptional surveillance 2024, no update required).
- U.S. Food and Drug Administration. Safety Communication: Laparoscopic Uterine Power Morcellation in Hysterectomy and Myomectomy. 2014.
- European Society for Gynaecological Endoscopy (ESGE) Uterine Fibroids Working Group. Good Practice Recommendations on surgical techniques for removal of fibroids: Part 1 (abdominal myomectomy) and Part 2 (hysteroscopic myomectomy). 2024.
Frequently asked questions
Is myomectomy or hysterectomy better for fibroids?
Neither is universally “better” — they serve different goals. Myomectomy removes fibroids while keeping the uterus and is preferred when future fertility or keeping the uterus matters. Hysterectomy removes the uterus and is the only option that ensures fibroids cannot recur; it suits women who have completed childbearing or have severe, recurrent disease. The right choice depends on your fibroids, your fertility plans, and your priorities.
Can fibroids come back after myomectomy?
Yes, new fibroids can develop over time, since the underlying tendency to form them remains after myomectomy. One long-term follow-up study reported a cumulative recurrence rate of around 5% at two years and 21% at five years, with a higher chance in women who had multiple fibroids removed or were aged 30–40 at the time of surgery. Individual risk varies, and this is a genuine trade-off worth discussing before surgery, not a reason to avoid myomectomy when preserving fertility matters.
Will I be able to get pregnant after a myomectomy?
Many women do, particularly when no other fertility factor is present. Myomectomy performed for fibroid-related infertility measurably improves the chance of pregnancy compared with leaving cavity-distorting fibroids in place. Your own chances depend on your age, ovarian reserve and the extent of surgery required, which is best assessed individually with your fertility team.
Is uterine artery embolisation a good alternative to surgery?
It can be, for women who are not good surgical candidates or do not wish to have surgery — randomised trial evidence shows it relieves symptoms comparably well to myomectomy in the medium term, though with a higher chance of needing a further procedure later. For women who want to preserve fertility, myomectomy generally offers better pregnancy and live-birth outcomes than embolisation, which can also affect ovarian reserve, so this trade-off should be discussed explicitly before choosing.
How do doctors decide which fibroids can be removed without a hysterectomy?
The decision rests mainly on imaging — a good pelvic ultrasound, and MRI when needed — to map the number, size and location of fibroids using the FIGO classification system. Fibroids bulging into the uterine cavity, or those in the muscle wall with enough healthy tissue around them for a durable repair, are generally suitable for myomectomy; a uterus extensively replaced by fibroid tissue may not be.
Reviewed by Dr. Priyadatt Patel, MBBS, MS — Balaji Horizon Women’s Hospital, Science City Road, Ahmedabad. Last reviewed: 21 July 2026.
Disclaimer: This article is for educational purposes only and does not replace a consultation with a qualified gynaecologist. Care is always individualised.
Free Patient Guide
The Fibroids Decision Guide
FIGO classification, when fibroids actually need treatment, the four decisions in care, surgery options including hysteroscopic and laparoscopic myomectomy. Aligned with ACOG, FIGO, ESGE/AAGL.
Get the guide →